The Latest from Mayo Clinic Laboratories
As the global reference laboratory for Mayo Clinic, Mayo Clinic Laboratories will help you advance patient care, strengthen your practice, and broaden access to specialized testing. Through our partnerships with clinicians at Mayo Clinic and health care providers around the world, we are able to offer the most sophisticated test catalog in the world. It is because of these daily collaborations that our subspecialized laboratories continue to be a critical component to patient care at Mayo Clinic.
Proposed regulations for laboratory developed tests
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the U.S. Food and Drug Administration’s (FDA) recently proposed rule that if finalized, would phase out its current enforcement discretion used for laboratory developed tests (LDTs), and regulate all laboratory tests as medical devices regardless of where they are manufactured.
Testing for Streptococcus pneumoniae antibodies
In this month’s “Hot Topic,” Melissa Snyder, Ph.D., identifies the clinical application of testing for Streptococcus pneumoniae polysaccharide antibodies and describes the tests available for measuring these antibodies.
|Anti-platelet factor 4 antibody-mediated prothrombotic syndromesIn this month’s “Virtual Lecture,” Anand Padmanabhan, M.B.B.S., Ph.D., associate professor of laboratory medicine and pathology at Mayo Clinic, provides a general overview and science in the field related to heparin-induced thrombocytopenia (HIT), vaccine-induced thrombotic thrombocytopenia (VITT), and monoclonal gammopathy of thrombotic significance (MGTS). The lecture also focuses on impacts related to diagnosis for anti-platelet factor 4-mediated thrombotic syndromes.|
Predictors to direct neural antibody testing in autoimmune encephalitis/epilepsy
In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses how applying the antibody prevalence in epilepsy and encephalopathy (APE2) score can decrease the number of uninformative or misleading autoimmune panel results, increase the yield of these ordering practices, and potentially point us toward characterizing patients who are likely to be seropositive.
Blood cultures webinar
Nov. 15, 2023 | 11 a.m.–Noon CT. Sepsis due to bacterial bloodstream infection is a medical emergency that requires prompt clinical intervention. Blood cultures can confirm the etiology of infection and help direct appropriate antimicrobial therapy. The utility of blood cultures is highly dependent on specimen collection. For this reason, medical institutions monitor several indicators of appropriate blood culture collection to ensure high-quality specimens are submitted to the diagnostic laboratory. This webinar will review proper blood culture collection techniques and demonstrate how specimen quality can impact patient care.
How to Order Testing
Many hospitals across the country have already established an account with Mayo Clinic Laboratories. Please click on the links below to register for an account or sign-in.
Registration for an account takes less than 10 minutes, and new accounts are typically processed and available in one business day. Once registered, sign in and locate the test in the Test Catalog and click the “Order This Test” button. Follow the prompts to provide billing and contact information. Print the test requisition form to ship with the specimen.
More from Mayo Clinic Laboratories
Want to read more about what’s happening at our labs? Visit our blog!